Trials / Conditions / Stage III Non-Small Cell Lung Cancer AJCC v7
Stage III Non-Small Cell Lung Cancer AJCC v7
6 registered clinical trials studyying Stage III Non-Small Cell Lung Cancer AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer NCT03455556 | Mayo Clinic | Phase 1 |
| Terminated | Collection of Blood Samples in Patients With Non-small Cell Lung Cancer NCT03492801 | University of Southern California | — |
| Completed | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malig NCT03229278 | Rutgers, The State University of New Jersey | Phase 1 |
| Terminated | Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma NCT02408016 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer NCT01993810 | Radiation Therapy Oncology Group | Phase 3 |
| Terminated | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small NCT01822496 | National Cancer Institute (NCI) | Phase 2 |